<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:03:11Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16975" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16975</identifier><datestamp>2026-10-18T20:56:45Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?</dc:title><dc:creator>Onat, Taylan</dc:creator><dc:creator>Doganyigit, Zuleyha</dc:creator><dc:creator>Caltekin, Melike Demir</dc:creator><dc:creator>Turkler, Can</dc:creator><dc:creator>Kaymak, Emin</dc:creator><dc:creator>Altindag, Mehmet Murat</dc:creator><dc:subject>Ischemia/reperfusion damage</dc:subject><dc:subject>oxidative stress</dc:subject><dc:subject>organ transplantation</dc:subject><dc:subject>lycopene</dc:subject><dc:subject>NF-KAPPA-B</dc:subject><dc:subject>ISCHEMIA-REPERFUSION INJURY</dc:subject><dc:subject>LIPID-PEROXIDATION</dc:subject><dc:subject>ACTIVATION</dc:subject><dc:subject>TRANSPLANTATION</dc:subject><dc:subject>TRANSCRIPTION</dc:subject><dc:subject>APOPTOSIS</dc:subject><dc:subject>RATS</dc:subject><dc:subject>Medicine, General &amp; Internal</dc:subject><dc:subject>General &amp; Internal Medicine</dc:subject><dc:description>Introduction: Ischernia/reperfusion damage (IRD) is one of the most important factors in the success of organ transplantation. IRD plays a role in both acute and chronic rejection. This study aims to evaluate the effects of lycopene, which is known to be a powerful antioxidant, on experimental uterine IRD. Methods: Twenty-four albino Wistar rats were included in the study and divided into three groups. No substances were administered the sham and ischemia/reperfusion groups. The ischemia/reperfusion and ischemia/reperfusion + lycopene groups were administered ischemia for 1 h and reperfusion for 2 h. The ischemia/reperfusion + lycopene group was administered 2.5 mg/kg lycopene reperfusion intraperitoneally half an hour before ischemia/reperfusion. Both uterine horns were extracted at the end of the procedure. Oxidative stress, inflammation, and apoptosis in the tissues were assessed. Results: The malondialdehyde level, nuclear factor kappa-B immunoreactivity, and apoptotic cell number in the lycopene-administered group (ischemia/reperfusion + lycopene) were significantly decreased compared with those in the ischemia/ reperfusion group (p&lt;0.05). Conclusion: The study found that lycopene reduced the effects of IRD on uterine tissue. Lycopene may positively affect the short- and long-term success of organ transplantation.</dc:description><dc:publisher>ISTANBUL TRAINING &amp; RESEARCH HOSPITAL</dc:publisher><dc:date>2021</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/16975</dc:identifier><dc:identifier>https://doi.org/10.4274/imj.galenos.2021.82698</dc:identifier><dc:identifier>2619-9793</dc:identifier><dc:language>en</dc:language><dc:relation>ISTANBUL MEDICAL JOURNAL</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/16975</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>